The authors of a 2013 paper on antibody production in patients with rheumatoid arthritis have retracted the work in what looks to us like a case study in how to handle operator error.
The paper, “Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition,” was published in the Journal of Experimental Medicine by a group from the Karolinska Institutet (KI) in Sweden and elsewhere, and has been cited 128 times, according to Clarivate Analytics’ Web of Science. The last author, Vivianne Malmström, is a specialist in cellular immunology at the KI.
Carlo Croce, the embattled cancer researcher at The Ohio State University (OSU), is suing the institution to reclaim the department chair he lost late last year for reasons that he says are unclear.
In a filing with the Franklin County civil court, Croce and his attorneys, from the Columbus firm of James E. Arnold and Associates, argue that the university failed to follow its own rules for demoting faculty members last year when it stripped Croce of his position of chair of the Department of Cancer Genetics and Biology. Croce had held the post for more than three consecutive four-year terms, starting in October 2004.
The authors of an much-ballyhooed 2017 paper about the spread of fake news on social media have retracted their article after finding that they’d botched their analysis.
The paper, “Limited individual attention and online virality of low-quality information,” presented an argument for why bogus facts seem to gain so much traction on sites such as Facebook. According to the researchers — — from Shanghai Institute of Technology, Indiana University and Yahoo — the key was in the sheer volume of bad information, which swamps the brain’s ability to discern the real from the merely plausible or even the downright ridiculous, competing with limited attention spans and time.
Last March, we reported on the retraction of a 2017 paper in Stem Cell Reports by Kohei Yamamizu and colleagues for widespread fabrication of figures. Turns out the problems were at least five years older than that.
Yamamizu had received a pink slip from his institution, the Center for iPS Cell Research and Application (CiRA), which had put the blame for the misconduct squarely on his shoulders. (The director of the institute, Nobel winner Shinya Yamanaka, also took some of the blame in a public statement in which he said he bore “a strong responsibility for not having prevented research misconduct at our institute.”)
Yamamizu has a new retraction, but this time’s a bit different. Here’s the notice for the paper, “Protein Kinase A Determines Timing of Early Differentiation through Epigenetic Regulation with G9,” which appeared in Cell Stem Cell in June 2012 (Yamanaka was not a co-author on either study). Although the statement acknowledges the internal investigation, it doesn’t mention misconduct or name Yamamizu: Continue reading Japanese stem cell fraud leads to a new retraction
We’ve seen plagiarizers plagiarizing plagiarizers, but here’s what seems to be a first: A journal has retracted an article that duplicated text…from a paper that had been retracted for containing dubious data.
The Journal of Applied Pharmaceutical Science published the recycled paper, titled “Development and in vitro-in vivo characterization of chronomodulated multi-particulate drug delivery system of terbutaline sulphate for treatment of nocturnal asthma by box–Behnken statistical design.” The authors were from several institutions in India.
The U.S. Office of Research Integrity has announced findings of misconduct against a once-promising pharmaceutical scientist at the University of Colorado.
The ORI says Rajendra Kadam fabricated data on government grants while working on his PhD at UC Denver under the supervision of Uday Kompella. As we reported in 2015 when this case first broke, Kadam was put in charge of a piece of technology that apparently he alone knew how to operate — giving him ample opportunity to cook results without fear of detection.